# Blood-Brain Barrier Penetration of Therapeutic Agents in Human

> **NCT04571996** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 4 (actual)

## Conditions studied

- CNS Disease

## Interventions

- **DRUG:** ODM-104
- **DRUG:** Paracetamol

## Key facts

- **NCT ID:** NCT04571996
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2021-02-23
- **Final completion:** 2021-02-23
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04571996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04571996, "Blood-Brain Barrier Penetration of Therapeutic Agents in Human". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04571996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*